SpectraScience Strengthens Intellectual Property Portfolio
September 08 2011 - 9:00AM
Marketwired
SpectraScience, Inc. (OTCQB: SCIE), a San Diego-based medical
device company, today announced it was recently granted a new
tissue-analysis patent, further strengthening its optical biopsy
patent portfolio. The patent granted is U.S. PATENT No. 8005527,
"Method for Determining a Condition of a Tissue." The patent can
provide the company expanded capabilities relating to its WavSTAT™
Optical Biopsy System using light-based techniques to differentiate
pre-malignant from normal tissue.
"The granting of this new patent is indicative of our commitment
to improving and expanding our already large intellectual property
portfolio in this space. The diagnosis and detection of cancer,
non-invasively using light, is becoming an increasingly more
important tool for oncologists," says Michael Oliver, President
& CEO of SpectraScience. Mr. Oliver continued, "We will
continue to emphasize developing new intellectual property to
support our current and future non-invasive, real-time cancer
diagnostic systems."
SpectraScience currently holds thirty-three U.S. Patents
relating to optical diagnostic systems and forceps, spectral
analysis and imaging techniques. In addition, the company holds
approximately twenty-five active foreign counterpart patents,
primarily in the European Union and Japan.
About SpectraScience, Inc.
SpectraScience is a San Diego-based medical device company that
designs, develops, manufactures and markets light-based analysis
systems capable of determining whether tissue is normal,
pre-cancerous or cancerous without physically removing tissue from
the body. The WavSTAT Optical Biopsy System uses light to optically
diagnose tissue and provide the physician with an immediate
analysis. With FDA approval for sale in the U.S. and the CE Mark
for the European Union, the WavSTAT System is the first
commercially available product that incorporates this innovative
technology for clinical use.
Contact: SpectraScience, Inc. Jim Dorst Chief Financial Officer
(858) 405-9933
SpectraScience (CE) (USOTC:SCIE)
Historical Stock Chart
From Mar 2024 to Apr 2024
SpectraScience (CE) (USOTC:SCIE)
Historical Stock Chart
From Apr 2023 to Apr 2024